Insmed Company
We are a publicly traded (NASDAQ: INSM) biopharmaceutical company dedicated to improving the lives of patients battling serious lung
Employee Number:
51-100
Funding Status:
IPO
Headquarters:
Bridgewater, New Jersey, United States
Technology:
Immunotherapy
Estimated Revenue:
$50M to $100M
Founded Date:
1988
Industry:
PharmTech